Jamie L. Reynoso
CIK 1839066 · CEO, Medicare Advantage · last filed 2026-06-11
Jamie L. Reynoso is a CEO, Medicare Advantage who has filed 62 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider sold $35.8K of CLOV on Jun 11, 2026. Across all open-market trades the lifetime net is −$385.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $13.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$13.48M
2
62
-$385.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLOV | CEO, Medicare Advantage | 2,849,921 | $4.73 | $13.48M | -$385.6K | 60 | 2026-06-11 |
| CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOVW) Delisted | Chief Operating Officer | 220,820 | $2.02 | $446.1K | $0 | 2 | 2021-07-20 |
Recent Filings
62 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | CLOV | Sell (S) | −7,289 | -$35.8K | EDGAR |
| 2026-04-16 | CLOV | Tax (F) | −12,712 | -$25.9K | EDGAR |
| 2026-04-07 | CLOV | Tax (F) | −6,197 | -$10.7K | EDGAR |
| 2026-04-03 | CLOV | Grant (A) | +159,384 | $0 | EDGAR |
| 2026-03-18 | CLOV | Sell (S) | −5,833 | -$11.1K | EDGAR |
| 2026-03-17 | CLOV | Tax (F) | −15,132 | -$30.0K | EDGAR |
| 2026-01-20 | CLOV | Mixed | −19,329 | -$53.3K | EDGAR |
| 2026-01-07 | CLOV | Sell (S) | −2,102 | -$5.3K | EDGAR |
| 2026-01-05 | CLOV | Tax (F) | −8,109 | -$19.5K | EDGAR |
| 2025-12-18 | CLOV | Sell (S) | −4,913 | -$12.8K | EDGAR |